Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.
Hose D, Ray S, Rößler S, Thormann U, Schnettler R, de Veirman K, El Khassawna T, Heiss C, Hild A, Zahner D, Alagboso F, Henss A, Beck S, Emde-Rajaratnam M, Burhenne J, Bamberger J, Menu E, de Bruyne E, Gelinsky M, Kampschulte M, Rohnke M, Wenisch S, Vanderkerken K, Hanke T, Seckinger A, Alt V.
Hose D, et al. Among authors: beck s.
J Hematol Oncol. 2024 Dec 18;17(1):128. doi: 10.1186/s13045-024-01636-4.
J Hematol Oncol. 2024.
PMID: 39695697
Free PMC article.